These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30589188)

  • 41. Short Linear Motifs in Colorectal Cancer Interactome and Tumorigenesis.
    Fasano C; Grossi V; Forte G; Simone C
    Cells; 2022 Nov; 11(23):. PubMed ID: 36496998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulators of 14-3-3 Protein-Protein Interactions.
    Stevers LM; Sijbesma E; Botta M; MacKintosh C; Obsil T; Landrieu I; Cau Y; Wilson AJ; Karawajczyk A; Eickhoff J; Davis J; Hann M; O'Mahony G; Doveston RG; Brunsveld L; Ottmann C
    J Med Chem; 2018 May; 61(9):3755-3778. PubMed ID: 28968506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evolution of protein-protein interaction network.
    Makino T; Gojobori T
    Genome Dyn; 2007; 3():13-29. PubMed ID: 18753782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Engineering Archeal Surrogate Systems for the Development of Protein-Protein Interaction Inhibitors against Human RAD51.
    Moschetti T; Sharpe T; Fischer G; Marsh ME; Ng HK; Morgan M; Scott DE; Blundell TL; R Venkitaraman A; Skidmore J; Abell C; Hyvönen M
    J Mol Biol; 2016 Nov; 428(23):4589-4607. PubMed ID: 27725183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved prediction of protein-protein interactions by a modified strategy using three conventional docking software in combination.
    Choi S; Son SH; Kim MY; Na I; Uversky VN; Kim CG
    Int J Biol Macromol; 2023 Dec; 252():126526. PubMed ID: 37633550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frontiers in PROTACs.
    Hughes GR; Dudey AP; Hemmings AM; Chantry A
    Drug Discov Today; 2021 Oct; 26(10):2377-2383. PubMed ID: 33872800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-Based Stabilization of Non-native Protein-Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design.
    Lin SM; Lin SC; Hsu JN; Chang CK; Chien CM; Wang YS; Wu HY; Jeng US; Kehn-Hall K; Hou MH
    J Med Chem; 2020 Mar; 63(6):3131-3141. PubMed ID: 32105468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors.
    Sheng C; Dong G; Miao Z; Zhang W; Wang W
    Chem Soc Rev; 2015 Nov; 44(22):8238-59. PubMed ID: 26248294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Homo- and Heterodimerization of Proteins in Cell Signaling: Inhibition and Drug Design.
    Singh SS; Jois SD
    Adv Protein Chem Struct Biol; 2018; 111():1-59. PubMed ID: 29459028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Structural Perspective on the Modulation of Protein-Protein Interactions with Small Molecules.
    Demirel HC; Dogan T; Tuncbag N
    Curr Top Med Chem; 2018; 18(8):700-713. PubMed ID: 29852872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MEGADOCK-Web: an integrated database of high-throughput structure-based protein-protein interaction predictions.
    Hayashi T; Matsuzaki Y; Yanagisawa K; Ohue M; Akiyama Y
    BMC Bioinformatics; 2018 May; 19(Suppl 4):62. PubMed ID: 29745830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A homologous mapping method for three-dimensional reconstruction of protein networks reveals disease-associated mutations.
    Huang SH; Lo YS; Luo YC; Tseng YY; Yang JM
    BMC Syst Biol; 2018 Mar; 12(Suppl 2):13. PubMed ID: 29560828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of Amino Acid Mutations and Small Molecules on Targeted Inhibition of Proteins Involved in Cancer.
    Kanakaveti V; Anoosha P; Sakthivel R; Rayala SK; Gromiha MM
    Curr Top Med Chem; 2019; 19(6):457-466. PubMed ID: 30836917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Small molecular weight protein-protein interaction antagonists: an insurmountable challenge?
    Dömling A
    Curr Opin Chem Biol; 2008 Jun; 12(3):281-91. PubMed ID: 18501203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tailoring peptidomimetics for targeting protein-protein interactions.
    Akram ON; DeGraff DJ; Sheehan JH; Tilley WD; Matusik RJ; Ahn JM; Raj GV
    Mol Cancer Res; 2014 Jul; 12(7):967-78. PubMed ID: 24642350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterizing Protein-Protein Interactions with the Fragment Molecular Orbital Method.
    Heifetz A; Sladek V; Townsend-Nicholson A; Fedorov DG
    Methods Mol Biol; 2020; 2114():187-205. PubMed ID: 32016895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improving small molecule virtual screening strategies for the next generation of therapeutics.
    Wingert BM; Camacho CJ
    Curr Opin Chem Biol; 2018 Jun; 44():87-92. PubMed ID: 29920436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New Compound Classes: Protein-Protein Interactions.
    Ottmann C
    Handb Exp Pharmacol; 2016; 232():125-38. PubMed ID: 26489828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Explore Protein-Protein Interactions for Cancer Target Discovery Using the OncoPPi Portal.
    Ivanov AA
    Methods Mol Biol; 2020; 2074():145-164. PubMed ID: 31583637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides.
    Lu MC; Yuan ZW; Jiang YL; Chen ZY; You QD; Jiang ZY
    Mol Biosyst; 2016 Apr; 12(4):1378-87. PubMed ID: 26935067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.